Skip to main content

Table 1 Effects of celecoxib administration (50 mg/kg/day, orally), and celecoxib plus royal jelly administration (300 mg/kg/day, orally) in comparison to the control group, on cardiac profile in male albino rats. Data are expressed as mean ± SD, n = 10/group

From: Cardioprotective role of royal jelly in the prevention of celecoxib-mediated cardiotoxicity in adult male albino rats

Groups

Cardiac profile

CPK (U/l)

CK-MB (U/l)

LDH (IU/l)

1

271.33 ± 27.61c

278.00 ± 13.11c

179.67 ± 9.29c

2

943.00 ± 63.17a

816.00 ± 117.04a

470.33 ± 49.17a

3

503.33 ± 175.02b

612.83 ± 49.49b

326.00 ± 51.09b

  1. Group (1) received no drug (control). Group (2) received celecoxib (50 mg/kg/day, orally), for 30 successive days. Group (3) received celecoxib (50 mg/kg/day, orally) and royal jelly (300 mg/kg/day, orally) for 30 successive days. Means carrying different superscripts in the same column are significant at p < 0.05